Epidemiology and Economic Burden of Nonmelanoma Skin Cancer

Facial Plastic Surgery Clinics of North America

Volumn 20, Issue 4, 2012, Pages 419-422

  Cakir, Burak Ömür ^a   Adamson, Peter ^b   Cingi, Cemal ^c  

^a SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Adamson Associates Cosmetic Facial Head and Neck Surgery Clinic   (Canada)

^c ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Head and neck cancer; Healthcare costs; Non melanoma skin cancer; Skin cancer costs; Skin cancer epidemiology

Indexed keywords

PROTEIN PATCHED;

AUSTRALIA; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER RISK; GENE MUTATION; HEALTH CARE COST; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LONGEVITY; NON MELANOMA SKIN CANCER; OZONE LAYER; PLASTIC SURGEON; PREVALENCE; PROSTATE CANCER; REVIEW; SKIN SURGERY; SUNLIGHT; ULTRAVIOLET RADIATION; UNITED STATES;

AUSTRALIA; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; EUROPE; HEALTH CARE COSTS; HUMANS; INCIDENCE; PREVALENCE; RISK FACTORS; SKIN NEOPLASMS; UNITED STATES;

EID: 84867805547     PISSN: 10647406     EISSN: 15581926     Source Type: Journal    
DOI: 10.1016/j.fsc.2012.07.004     Document Type: Review

References (20)

1. Nyugen T.H., Ho D.D. Nonmelanoma skin cancer. Curr Treat Options Oncol 2002, 3:193-203.
2. Brougham N.D., Dennett E.R., Tan S.T. Non-melanoma skin cancers in New Zealand-a neglected problem. N Z Med J 2010, 123:59-65.
3. Staples M.P., Elwood M., Burton R.C., et al. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust 2006, 184:6-10.
4. Raasch B.A., Buettner P.G. Multiple nonmelanoma skin cancer in an exposed Australian population. Int J Dermatol 2002, 41:652-658.
5. Rogers H.W., Weinstock M.A., Harris A.R., et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 2010, 146:283-287.
6. Stern R.S. Prevalence of a history of skin cancer in 2007: results of an incidence-based model. Arch Dermatol 2010, 146:283-287.
7. Madera P.A., Eisman A.B., Santiago S.A., et al. Changes in the incidence of skin cancer between 1978-2002. Actas Dermosifiliogr 2010, 101:39-46.
8. Lomas A., Leonardi-Bee J., Bath-Extall F. A systematic review of worldwide incidence on non-melanoma skin cancer. Br J Dermatol 2012, 166(5):1069-1080.
9. Guy G.P., Ekwueme D.U. Years of potential life lost and indirect costs of melanoma and non-melanoma skin cancer: a systematic review of the literature. Pharmacoeconomics 2011, 29:863-874.
10. Mudigonda T., Pearce D.J., Yentzer B.A., et al. The economic impact of non-melanoma skin cancer: a review. J Natl Compr Canc Netw 2010, 8:888-896.
11. Housman T.S., Feldman S.R., Williford P.M., et al. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol 2003, 48:425-429.
12. Tierney E.P., Hanke C.W. Cost effectiveness of Mohs micrographic surgery: review of the literature. J Drugs Dermatol 2009, 8:914-922.
13. Chen G.J., Yelverton C.B., Polisetty S.S., et al. Treatment patterns and cost of nonmelanoma skin cancer management. Dermatol Surg 2006, 32:1266-1271.
14. Chen G.J., Fleischer A.B., Smith E.D., et al. Cost of nonmelanoma skin cancer treatment in the United States. Dermatol Surg 2001, 27:1035-1038.
15. Asgari M.M., Bertenthal D., Sen S., et al. Patient satisfaction after treatment of nonmelanoma skin cancer. Dermatol Surg 2009, 35:1041-1049.
16. Health system expenditures on cancer and other neoplasms in Australia, 2000-01 2005, Australian Institute of Health and Welfare, Canberra (Australia), Report No.: 22.
17. Australian Government Department of Health and Ageing. Health Fact Sheet 1-Investing in Australia's health: strengthening cancer care, Available at: Accessed November 22, 2005. mailto:http://www.health.gov.au/internet/budget/Publishing.nsf/Content/health-budget2005-hbudget-hfact1.htm.
18. 2004-2006 Data from National Clinical and Health Outcomes Knowledge Base of UK, (NCHOD).
19. Stang A., Stausberg J., Boedeker W., et al. Nationwide hospitalization costs of skin melanoma and non-melanoma skin cancer in Germany. J Eur Acad Dermatol Venereol 2008, 22:65-72.
20. Tinghög G., Carlsson P., Synnerstad I., et al. Societal Cost of Skin Cancer in Sweden in 2005. Acta Derm Venereol 2008, 88:467-473.